Earth Science Tech, Inc. (ETST) Sees Uplisting to OTCQB Venture Market as Key to Goal of being Global Leader in Cannabinoid Market
Biotech company is focused on becoming a worldwide leader in R&D and sale of hemp-derived, CBD-based nutraceuticals, pharmaceuticals and dietary supplements ETST is developing three new CBD formulas in Canada under a provisory patent; it is also clinical testing its Hygee medical device for detecting sexually transmitted diseases in women With its Form 10 Registration Statement filing now effective, ETST will begin reporting annual, quarterly and periodic financial statements Earth Science Tech, Inc. (OTCQB: ETST) anticipates that its uplisting to the OTCQB Venture Market will enable it to reach global recognition and increase liquidity as a leader in the hemp-based…